Market Overview

Afternoon Market Movers

Share:
Related LGND
Benzinga's Top Upgrades, Downgrades For September 5, 2017
Analyst Makes The Case For Ligand As A 'Core' Holding
Mirati Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90 (Investor's Business Daily)
Related FNSR
Watch These 4 Huge Put Purchases In Monday Trade
Benzinga's Option Alert Recap From September 15
Finisar Demonstrates Industry’s First –……G QSFP—8 eSWDM Extended Reach and –…G ... (GuruFocus)

Market Gainers

Ligand Pharmaceuticals (NASDAQ: LGND) soared 14.10 percent to $36.90 after the company announced ownership limit for BVF to 25% of outstanding shares.

Finisar (NASDAQ: FNSR) shot up 11.78 percent to $16.23 after the company reported upbeat fiscal four-quarter earnings and issued strong forecast for the first quarter.

ChinaEdu (NASDAQ: CEDU) gained 7.70 percent to $6.29 after the company announced receipt of "Going Private" proposal at $7.00 per ADS.

Medical Group (NASDAQ: WMGI) traded up 5.82 percent to $26.40 after the company announced its plans to sell its implants business to a unit of MicroPort Scientific for $290 million in cash.

Market Losers

Ebix (NASDAQ: EBIX) plummeted 40.64 percent to $11.71 reaching a new 52-week low after the company and affiliate of Goldman Sachs (NYSE: GS) agreed to terminate a merger agreement.

Rio Alto Mining (NYSE: RIOM) dropped 15.90 percent to $2.01 after the company's RSI reading landed at 28.8.

FuelCell Energy (NASDAQ: FCEL) dipped 12.61 percent to $1.18 after the company priced senior unsecured convertible notes offering.

Posted-In: News Intraday Update Markets Movers Reviews

 

Related Articles (CEDU + EBIX)

View Comments and Join the Discussion!
Loading...
Loading...